Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Alissa Groenendijk

Alissa Groenendijk

PhD student
Treatment of recurrent Wilms’ tumors
Phone 088 97 25 633

Despite the recent advances in Wilms’ Tumor (WT) treatment, 15% of patients present with recurrent disease. To improve overall survival following recurrent WT, the novel UMBRELLA protocol promotes the first international shared approach in treating relapsed WT. The current project is focused on the retrospective validation of the UMBRELLA treatment guidelines and the identification of prognostic factors for recurrent WT. In addition, we aim to develop organoids derived from relapsed WT tissue to ultimately perform patient specific drug screens.